On the prediction platform Manifold Markets, 11 traders have wagered on a remarkable question: whether an average New Zealander born at the turn of the millennium will live to 150. The market currently assigns a 38% chance to this outcome, reflecting a blend of optimism about future medical breakthroughs and skepticism about the limits of human lifespan. The event is set to resolve in just one week, though the question's phrasing—referring to an 'average' person—adds ambiguity, as it likely depends on statistical life expectancy projections rather than a single individual's fate.
No specific external trigger was identified in today's news flow to explain the current probability. The market's relatively low participation (11 players) and lack of volume data suggest this is a niche, speculative bet rather than a heavily traded forecast. The 38% figure implies that traders see a meaningful but far-from-certain path to extreme longevity, likely tied to hypothetical advances in anti-aging therapies, genetic engineering, or regenerative medicine. However, without broader market data from platforms like Kalshi or Polymarket, the forecast should be treated as indicative rather than definitive.